Latest news
Alusid achieves milestone in European roll out with first stocking agreement
Portfolio company Alusid has reached an important milestone in its European roll out plans following an agreement with Tegelgroep Nederland, a leading wholesaler across Belgium, the Netherlands and Luxembourg.
Read moreWatch: TVG CEO Dr Jeremy Salt on company’s next steps following Streptococcus suis vaccine success
The Vaccine Group’s recent success in trials for a Streptococcus suis vaccine follows that of its bovine respiratory syncytial virus vaccine candidates. Jeremy discusses their significance and the Company’s next steps.
Read moreStrong results for TVG vaccine against zoonotic pig disease Streptococcus suis
Challenge trials showed TVG vaccine candidate follows outstanding success in bovine respiratory syncytial virus and demonstrates the technology’s efficacy against diseases in different animals and against different pathogens.
Read moreOur portfolio
Our portfolio companies are involved in developing a wide range of technologies based on cutting-edge intellectual property to meet the needs and demands of the world.
See all companiesDekiln
Dekiln, formerly known as DeakinBio, has developed BioSintering®, a technology combining waste materials such as gypsum powder with bio-based active ingredients to produce a revolutionary, low-carbon alternative to traditional ceramic tiles.
Learn more